Use access key #2 to skip to page content.
$5.32 0.62 (13.19%)
7/8/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View Ticker Page (EXEL)

Results 31 - 40 of 350 :   12345Next »

Recs

2

Avatar TMFselzhanik (87.53) Submitted: 4/25/07 11:37 AM : Outperform Start Price: $8.85 EXEL Score: -34.19

My unborn daughter had some fantastic points about the stock:
http://www.votigo.com/contests/showentry/2985

Despite my concerns that they are bleeding cash at $10 million per month, she assures me that the expenses are primarily going into R&D, and ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar Fatherof9 (< 20) Submitted: 6/05/07 3:49 PM : Outperform Start Price: $11.02 EXEL Score: -34.58

This is the first stock I've ever purchased. I did so based on reading the Rule Breaker newsletter for the last year. So my rationale is I trust the experts. I would recommend that no one trust my stockpicking expertise.

Report this Post Replies: 1 | Reply | Permalink

Recs

2

Avatar MrBuffyJr (79.58) Submitted: 9/28/06 2:47 AM : Outperform Start Price: $9.00 EXEL Score: -35.92

EXEL is building a strong pipeline in Cancer, diabetic nephropathy and other drugs. Two of the nine drugs in its pipeline are in the last stage of research and are showing strong clinical data that point out high probability of success of both. In ad...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar SureBeatsWorking (82.62) Submitted: 5/09/07 9:45 PM : Outperform Start Price: $11.51 EXEL Score: -38.17

I'm no expert on pharmaceutical companies, but I know a man who is!

I can't believe I didn't add it to CAPS earlier, it must have slipped my mind somehow. With positive phase 2 testing for XL647 I looked for it in my CAPS portfolio and couldn't find...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar dbhealylongonly (< 20) Submitted: 5/24/08 2:47 PM : Outperform Start Price: $6.11 EXEL Score: -5.24

I usually try to avoid biotech companies, given their inherent volatility (and my propensity to lose sleep when they're in my portfolio!). In this case however, I'm making a speculative bet that these guys will find a way to develop and market their...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar antonioexpo (< 20) Submitted: 8/28/06 4:14 AM : Outperform Start Price: $8.20 EXEL Score: -33.22

The next big biotech

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar 1lenzman (< 20) Submitted: 7/08/07 8:52 PM : Outperform Start Price: $11.95 EXEL Score: -38.53

Over 14 new drugs, mostly related to tumor and cancer treatments. A large number of Big Biopharma companies in pacts with this company. Their scientific approach looks to be extraordinary and successful. It will take time for this to see big retur...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar bluedough (< 20) Submitted: 8/29/06 4:59 PM : Outperform Start Price: $8.42 EXEL Score: -34.70

I like EXEL as a speculative pick in biotech because unlike some other ridiculous companies, EXEL HAS THEIR NOSE TO THE GRINDSTONE actually doing something with their cash burn. Even getting a drug to phase II is no small feat, and they have a pipel...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar 11x (< 20) Submitted: 4/05/07 1:22 PM : Underperform Start Price: $10.50 EXEL Score: 37.53

You don't buy stocks just because they have a big pipeline of variouis drugs in Phase I, II. At least wait until one has positive Phase III and submits for FDA approval. This is too early in the game and results have not been impressive so far.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar spinbob7 (25.59) Submitted: 6/16/06 12:08 AM : Outperform Start Price: $10.56 EXEL Score: -51.17

Very deep pipeline and good partnerships will allow this young biotech to bring numerous drugs to market beginning around 2010.

Report this Post Replies: 1 | Reply | Permalink

Featured Broker Partners